R-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid

We are R-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid CAS:181289-33-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:R-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid
CAS.NO:181289-33-8
Synonyms:
(3R)-3-(2-AMino-2-oxoethyl)-5-Methylhexanoic Acid
(R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid
3-CarbaMoyl Mehyl-5-Methyl Hexanoic Acid
(r)-(-)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid
(3R)-3-(carbamoylmethyl)-5-methylhexanoic acid
(r)-(-)-3-carbamoymethyl-5-methylhexanoic acid
INTERMEDIATE OF PREGABALIN

Molecular Formula: C9H17NO3
Molecular Weight: 187.23600

Physical and Chemical Properties:
Density: 1.081g / cm3
Boiling point: 401.929ºC at 760 mmHg
Melting point: 128-133ºC
Flash point: 196.88ºC
Refractive index: 1.475

Specification:
Appearance: White to off-white crystalline powder
Purity:≥99%
Loss On Drying: < 0.30%
Heavy metal: < 20ppm
Impurity: <0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Pregabalin CAS:148553-50-8

Related News: The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.5-Cyanophthalide In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.3,4-Difluorobenzoic acid CAS:455-86-7 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.2-(Trifluoromethyl)acrylic acid CAS:381-98-6 At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.